Question 1

Is there a generic for Ertugliflozin; sitagliptin phosphate?

Accepted Answer

The FDA Orange Book does not currently list an approved generic (ANDA) for Ertugliflozin; sitagliptin phosphate. It is available as 1 brand (NDA) application.

Question 2

What is the reference-listed drug for Ertugliflozin; sitagliptin phosphate?

Accepted Answer

STEGLUJAN (NDA 209805, MSD SUB MERCK) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

Question 3

What patents protect Ertugliflozin; sitagliptin phosphate?

Accepted Answer

The Orange Book lists 5 patents against Ertugliflozin; sitagliptin phosphate products, with the earliest listed expiry in 2026. Listed patents cover the drug substance, drug product, or approved methods of use, and a generic launching before they expire must file a Paragraph IV certification.

Question 4

What dosage forms of Ertugliflozin; sitagliptin phosphate are approved?

Accepted Answer

Ertugliflozin; sitagliptin phosphate is approved in the following dosage form: tablet.

Patent	Expires	In	Type
7326708	Nov 24, 2026	in 5 mo	SubstanceProductU-2214
7326708*PED	May 24, 2027	in 11 mo
9439901	Oct 21, 2030	in 4 yr 5 mo	U-2214
9308204	Oct 21, 2030	in 4 yr 5 mo	Product
8080580	Dec 19, 2031	in 5 yr 7 mo	SubstanceProductU-2214

Ertugliflozin; sitagliptin phosphate

Brand (NDA) products · tablet

Listed patents (5)

Ertugliflozin; sitagliptin phosphate — frequently asked questions

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.